av/bone-therapeutics--big.svg

COM:BIOSENIC

BioSenic

  • Stock

EUR

Last Close

0.01

25/11 08:29

Market Cap

3.49M

Beta: -

Volume Today

33.80K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
average payables
1.99M
-
2.34M
17.10%
2.07M
11.26%
2.57M
23.88%
3.02M
17.82%
3.16M
4.31%
4.12M
30.57%
4.84M
17.39%
3.25M
32.89%
2.79M
13.99%
average receivables
70.50K
-
book value per share
-2.80
-
4.26
252.24%
2.23
47.73%
0.35
84.39%
0.59
69.61%
0.21
63.61%
0.28
32.10%
-101.90
36,027.38%
0.03
100.03%
-0.17
664.49%
capex per share
-0.89
-
-0.47
47.41%
-0.09
81.23%
-0.06
31.29%
-0.04
35.81%
-0.03
16.44%
-0.01
75.59%
-3.12
39,204.00%
-0.00
100.00%
capex to depreciation
-8.15
-
-7.87
3.47%
-1.12
85.70%
-0.79
29.59%
-0.51
35.56%
-0.41
19.33%
-0.15
62.41%
-1.11
619.20%
-0.08
92.51%
capex to operating cash flow
0.86
-
0.26
69.29%
0.05
79.84%
0.04
29.10%
0.02
39.09%
0.03
29.92%
0.01
80.60%
0.02
180.00%
0.00
83.83%
capex to revenue
-10.12
-
-0.30
97.08%
-0.09
-
-0.21
122.58%
cash per share
3.42
-
5.09
48.95%
2.96
41.81%
1.23
58.57%
1.07
12.54%
0.91
15.73%
1.25
38.06%
161.32
12,811.02%
0.02
99.99%
0.00
94.44%
days of inventory on hand
days payables outstanding
days sales outstanding
94.78
-
debt to assets
0.78
-
0.25
68.47%
0.32
30.32%
0.47
45.78%
0.50
6.44%
0.61
22.72%
0.60
2.71%
1.05
76.55%
0.71
32.46%
2.87
303.36%
debt to equity
-2.00
-
0.44
122.12%
0.81
83.97%
4.95
509.44%
2.86
42.22%
6.70
133.99%
4.45
33.54%
-3.07
169.08%
5.91
292.19%
-1.20
120.23%
dividend yield
earnings yield
-0.11
-
-0.11
3.88%
-0.24
121.53%
-0.23
5.06%
-0.42
79.51%
-0.30
27.52%
-0.39
30.19%
-292.32
74,523.35%
-0.18
99.94%
-3.43
1,838.90%
enterprise value
61.54M
-
107.45M
74.61%
45.43M
57.72%
58.53M
28.83%
38.93M
33.49%
39.85M
2.37%
30.63M
23.14%
11.33M
63.00%
30.52M
169.33%
36.43M
19.36%
enterprise value over ebitda
-11.99
-
-9.00
24.97%
-3.76
58.25%
-5.06
34.59%
-2.97
41.19%
-4.49
51.13%
-2.12
52.90%
-0.96
54.63%
-13.47
1,303.09%
-5.36
60.20%
ev to operating cash flow
-17.46
-
-9.13
47.70%
-4.00
56.25%
-5.31
32.93%
-3.02
43.20%
-3.83
26.99%
-1.90
50.29%
-0.89
53.46%
-15.98
1,702.66%
-10.50
34.30%
ev to sales
1.43K
-
38.93
97.27%
30.63
-
11.33
63.00%
67.09
-
free cash flow per share
-1.93
-
-2.25
16.46%
-1.75
22.39%
-1.67
4.51%
-1.73
3.89%
-1.12
35.25%
-1.38
22.88%
-195.68
14,082.33%
-0.02
99.99%
-0.03
58.85%
free cash flow yield
-0.12
-
-0.12
4.39%
-0.22
94.29%
-0.21
7.65%
-0.39
85.84%
-0.31
20.06%
-0.53
72.27%
-293.81
55,266.46%
-0.17
99.94%
-0.41
149.17%
graham net net
-6.53
-
1.72
126.39%
-0.44
125.54%
-2.10
376.92%
-1.72
18.08%
-1.23
28.60%
-0.59
52.33%
-238.40
40,628.39%
-0.20
99.91%
-0.23
15.33%
graham number
10.33
-
14.34
38.80%
9.75
31.99%
3.82
60.86%
4.98
30.46%
2.30
53.78%
2.55
10.76%
668.10
26,105.99%
0.11
99.98%
0.89
739.11%
income quality
0.63
-
0.96
53.65%
0.89
7.71%
0.90
0.89%
1.13
25.55%
1.09
3.49%
0.92
15.12%
1.06
15.33%
0.82
22.49%
0.12
85.37%
intangibles to total assets
0.00
-
0.00
37.46%
0.00
5.98%
0.00
17.89%
0.00
28.32%
0.00
46.37%
0.00
9.83%
0.00
3.18%
0.65
55,878.24%
0.31
51.98%
interest coverage
-22.15
-
-43.04
94.33%
-32.99
23.36%
-29.06
11.89%
-38.09
31.07%
-28.08
26.30%
-22.15
21.11%
-14.23
35.74%
-8.34
41.41%
-1.18
85.82%
interest debt per share
5.67
-
1.93
66.02%
1.87
3.04%
1.78
4.47%
1.73
3.17%
1.48
14.39%
1.32
10.78%
326.00
24,596.54%
0.18
99.95%
0.24
38.47%
inventory turnover
invested capital
-2.00
-
0.44
122.12%
0.81
83.97%
4.95
509.44%
2.86
42.22%
6.70
133.99%
4.45
33.54%
-3.07
169.08%
5.91
292.19%
-10.31M
174,506,128.61%
market cap
54.17M
-
128.63M
137.45%
53.32M
58.54%
55.14M
3.40%
34.25M
37.89%
34.77M
1.52%
30.48M
12.33%
44.22K
99.85%
11.53M
25,983.13%
8.39M
27.28%
net current asset value
-14.43M
-
19.46M
234.91%
5.16M
73.51%
-8.18M
258.55%
-6.26M
23.40%
-8.61M
37.53%
-2.69M
68.73%
-12.25M
354.73%
-21.57M
76.17%
-30.42M
40.99%
net debt to ebitda
-1.44
-
1.77
223.52%
0.65
63.21%
-0.29
144.90%
-0.36
21.99%
-0.57
60.34%
-0.01
98.20%
-0.96
9,189.31%
-8.38
776.33%
-4.13
50.75%
net income per share
-1.69
-
-2.14
26.54%
-1.90
11.52%
-1.86
1.82%
-1.87
0.35%
-1.10
41.29%
-1.02
7.13%
-194.69
19,015.06%
-0.02
99.99%
-0.21
1,136.05%
operating cash flow per share
-1.04
-
-1.78
71.27%
-1.66
6.89%
-1.61
3.09%
-1.70
5.38%
-1.09
35.68%
-1.37
25.82%
-192.56
13,937.06%
-0.02
99.99%
-0.03
59.26%
payables turnover
receivables turnover
3.85
-
research and ddevelopement to revenue
320.05
-
12.88
95.97%
15.42
-
11.68
24.21%
7.24
-
return on tangible assets
-0.24
-
-0.28
18.39%
-0.34
19.92%
-0.51
50.44%
-0.55
8.95%
-0.47
15.35%
-0.48
2.90%
-0.65
35.97%
-0.20
69.51%
-4.38
2,095.26%
revenue per share
0.01
-
0.13
2,095.11%
0.09
-
15.06
17,558.32%
0.00
-
roe
0.60
-
-0.50
183.12%
-0.85
69.28%
-5.35
529.10%
-3.17
40.84%
-5.11
61.34%
-3.59
29.70%
1.91
153.20%
-0.58
130.30%
1.26
316.99%
roic
-0.59
-
-0.30
48.88%
-0.45
50.45%
-0.87
90.91%
-0.66
24.12%
-0.70
5.87%
-0.83
19.08%
-0.83
0.25%
-0.06
92.70%
-1.57
2,500.20%
sales general and administrative to revenue
36.85
-
1.72
95.33%
1.81
-
1.77
2.54%
6.72
-
shareholders equity per share
-2.80
-
4.26
252.24%
2.23
47.73%
0.35
84.39%
0.59
69.61%
0.21
63.61%
0.28
32.10%
-101.90
36,027.38%
0.03
100.03%
-0.17
669.64%
stock based compensation to revenue
-2.17
-
0.05
102.40%
0.27
-
-0.10
137.22%
tangible asset value
-9.54M
-
28.08M
394.38%
15.21M
45.82%
2.35M
84.53%
4.47M
89.93%
2.02M
54.80%
3.30M
63.22%
-6.79M
305.88%
-15.97M
135.28%
-25.69M
60.88%
tangible book value per share
-2.82
-
4.25
251.02%
2.22
47.79%
0.34
84.53%
0.59
70.93%
0.21
63.93%
0.28
32.80%
-102.25
36,455.68%
-0.13
99.87%
-0.19
41.03%
working capital
-7.10M
-
31.16M
538.85%
17.96M
42.36%
4.02M
77.63%
5.67M
41.22%
2.39M
57.80%
9.03M
277.07%
7.62M
15.61%
-5.73M
175.18%
-14.00M
144.42%

All numbers in EUR (except ratios and percentages)